The serum alkaline phosphatase ( ALP ) levels and the Mayo risk score in the combination therapy group ( mean @IU/l and @ , respectively ) were significantly lower than those in the UDCA monotherapy group ( mean @IU/l and @ , respectively ) at @ years after the beginning of the study ( P < @ ) .